Drug Type Small molecule drug |
Synonyms ALDOCLOR-250, Aldoclor-150 |
Target |
Action agonists, inhibitors |
Mechanism ADRA2 agonists(Adrenergic receptors alpha-2 agonists), NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseWithdrawn |
First Approval Date United States (20 Mar 1968), |
Regulation- |
Molecular FormulaC7H6ClN3O4S2 |
InChIKeyJBMKAUGHUNFTOL-UHFFFAOYSA-N |
CAS Registry58-94-6 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |





